ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0191

Reproductive Health Discussions Between Rheumatology Providers and Systemic Lupus Erythematosus Patients: A Survey of English and Spanish-Speaking Patients

Meredith Xepoleas1, Martha Delgado2, Jack Rodman3, Julia Simard4, Sandy Lee5 and Leanna Wise6, 1Keck School of Medicine of University of Southern California, Los Angeles, CA, 2LAC+USC/Keck School of Medicine, Los Angeles, CA, 3University of Southern California, Los Angeles, CA, 4Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 5University of Southern California, Walnut, CA, 6LAC+USC/Keck Medicine of USC, Pasadena, CA

Meeting: ACR Convergence 2023

Keywords: Disparities, pregnancy, quality of care, race/ethnicity, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0176–0195) Healthcare Disparities in Rheumatology Poster I: Lupus

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) primarily affects women of childbearing age, with a higher burden in non-Caucasian populations. Due to the increased risk of adverse pregnancy outcomes in SLE, especially among non-Caucasian patients, it is essential for rheumatologists to engage patients in reproductive health discussions. Our study aims to gain insight into the conversations surrounding reproductive health between rheumatology providers and a primarily Hispanic SLE population, with a focus on disparities between English-speaking and Spanish-speaking populations.

Methods: A 28-question survey based on the American College of Rheumatology 2020 Reproductive Health Guideline was developed, covering contraception, preconception counseling, and pertinent peri-partum issues. The survey was offered in either English or Spanish to female patients with SLE between the ages of 18 – 50, at a safety-net outpatient rheumatology clinic in urban Los Angeles. Data were presented using frequency (%) or median (IQR) and evaluated using Fisher’s exact or Wilcoxon rank sum test, as appropriate.

Results: From March 15 2023, to May 16 2023, 61 surveys were collected. Response rate was 92%. Participants identified as Hispanic (84%), with 71% expressing an English-language preference (Table 1). For all respondents who reported being sexually active with a male partner, 29% denied use of any kind of birth control, and only 25% noted effective contraception (long-acting reversible contraception or sterilization) (Table 1). Approximately 60% of all patients who sought pregnancy after SLE diagnosis took hydroxychloroquine (Table 2). However, while 73% of English-survey respondents noted that a rheumatologist advised them to be on hydroxychloroquine during the pre-conception/pregnancy period, only 60% of Spanish-speaking individuals were given the same counsel (Table 2). English-language respondents reported a significantly higher frequency of conversations in the past one year regarding contraception and pregnancy planning compared to Spanish-speaking respondents (72% vs. 33% and 76% vs. 39%, respectively; Table 2).

Conclusion: This study highlights the importance of thorough reproductive health discussions for patients with SLE, especially in a primarily Hispanic population. For a population known to have high rates of teratogenic medication use and/or poorly controlled disease activity, suboptimal contraception was common. Some disparities between the English and Spanish speaking population include the English-speaking population had a higher rate of conversations surrounding contraception and pregnancy in the past one year, compared to the Spanish speaking patients. This suggests potential barriers in the Spanish-speaking patient population. Hydroxychloroquine use during pregnancy or for those trying to conceive was low, although only patients who ever attempted to conceive or had a pregnancy after SLE diagnosis answered this question. Further research should explore ways of optimizing reproductive health conversations, especially regarding hydroxychloroquine and contraception use, in the management of Hispanic SLE populations.

Supporting image 1

Table 1. Demographics of Female Systemic Lupus Erythematosus Patients

Supporting image 2

Table 2. Pre-conception questions by survey language(1)

Numbers represent frequency (column percent).
*While 17 respondents noted that they prefer receiving medical care in Spanish, only 14 of these elected to take the Spanish language survey
(1)Some respondents did not answer all questions
(2)Due to branching logic, not all participants answered each question and not all cells will add to the full study population. Individuals who did not attempt and/or experience a pregnancy after SLE diagnosis did not answer questions about hydroxychloroquine use during the pre-conception period or pregnancy.


Disclosures: M. Xepoleas: None; M. Delgado: None; J. Rodman: None; J. Simard: None; S. Lee: None; L. Wise: AstraZeneca, 6, Aurinia Pharma, 2, 6, GlaxoSmithKlein(GSK), 6.

To cite this abstract in AMA style:

Xepoleas M, Delgado M, Rodman J, Simard J, Lee S, Wise L. Reproductive Health Discussions Between Rheumatology Providers and Systemic Lupus Erythematosus Patients: A Survey of English and Spanish-Speaking Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/reproductive-health-discussions-between-rheumatology-providers-and-systemic-lupus-erythematosus-patients-a-survey-of-english-and-spanish-speaking-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reproductive-health-discussions-between-rheumatology-providers-and-systemic-lupus-erythematosus-patients-a-survey-of-english-and-spanish-speaking-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology